29/09/22 -"Significant increase in FY22 revenue and EBIT margin forecast due to better component availability, price increases and FX effects"
29/09/22 -"Significant increase in FY22 revenue and EBIT margin forecast due to better component availability, price increases and FX effects"
AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.
Corporate broking | NO |
Trading in corporate shares | NO |
Analyst ownership | NO |
Advising of corporate (strategy, marketing, debt, etc) | NO |
Research paid for by corporate | NO |
Provision of corporate access paid for by corporate | NO |
Link between and a banking entity | NO |
Brokerage activity at AlphaValue | NO |